Recall Enforment Report D-0280-2019

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Upsher Smith Laboratories, Inc., originally initiated on 09-19-2018 for the product Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11 The product was recalled due to failed impurities/ degradation specifications: product is out of specification for an unspecified degradation product.. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0280-201909-19-201810-31-2018Class II44,764 bottlesBumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.Terminated
D-0281-201909-19-201810-31-2018Class II29,080 bottlesBumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0542-11Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.Terminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0832-0540Bumetanide BumetanideTabletOralUpsher-smith Laboratories, LlcHuman Prescription Drug
0832-0541Bumetanide BumetanideTabletOralUpsher-smith Laboratories, LlcHuman Prescription Drug
0832-0542Bumetanide BumetanideTabletOralUpsher-smith Laboratories, LlcHuman Prescription Drug